MREC Reviewer Comment
Protocol Title
A Prospective Clinical Study to Evaluate the Therapeutic Efficacy and Clinical Safety of Strogenzo in the Management of Perimenopausal and Menopausal Symptoms
Completely satisfied and informative data
Needs Explanation
Comments to the applicant
1-Age range of participants has wide range of women aged 40–60 years?
2-As the start dosage is 100 mg twice daily for the first month
How do you know that women had hypersensitivity to any component of Strogenzo?.
Comment to the Committee
Age range of participants has wide range of women aged 40–60 years?
Well organizes Gantt Chart
Exclusion Criteria: As the start dosage is 100 mg twice daily for the first month
How do you know that women had hypersensitivity to any component of Strogenzo?.
تمت الاجابة من خلال بيانات لموافقة-المستنيرة
Informed consent form:
Accepted
